Sotorasib
Showing 1 - 25 of 42
Healthy Participants Trial (Sotorasib)
Not yet recruiting
- Healthy Participants
- Sotorasib
- (no location specified)
Sep 25, 2023
NSCLC Metastatic Trial in Stockholm (Stereotactic body radiation therapy (SBRT), Temporary Stopping)
Recruiting
- Non-small Cell Lung Cancer Metastatic
- Stereotactic body radiation therapy (SBRT)
- Temporary Stopping
-
Stockholm, Solna, SwedenKarolinska University Hospital
Nov 9, 2023
Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)
Not yet recruiting
- Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
- Sotorasib
- Ladarixin
-
New York, New YorkNYU Langone Health
Apr 4, 2023
Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)
Not yet recruiting
- Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
- Sotorasib
- Ladarixin
-
New York, New YorkNYU Langone Health
Apr 4, 2023
Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)
Active, not recruiting
- Efficacy
- Oral sotorasib + IV Panitumumab
-
Seoul, Korea, Republic ofKorea University Anam Hospital
Aug 14, 2023
NSCLC (NSCLC) Trial (Sotorasib, Pembrolizumab)
Not yet recruiting
- Non-Small Cell Lung Cancer (NSCLC)
- Sotorasib
- Pembrolizumab
- (no location specified)
Jun 26, 2023
Healthy Participants Trial in United States (Sotorasib)
Completed
- Healthy Participants
- Sotorasib
-
Daytona Beach, Florida
- +3 more
Nov 3, 2022
Non Small Cell Lung Cancer Trial in Seoul (sotorasib)
Not yet recruiting
- Non Small Cell Lung Cancer
- sotorasib
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jul 5, 2022
KRAS P.G12C, Non Small Cell Lung Cancer Trial in France (Sotorasib 120Mg Tab)
Recruiting
- KRAS P.G12C
- Non Small Cell Lung Cancer
- Sotorasib 120Mg Tab
-
Lyon, France
- +3 more
Dec 16, 2022
Healthy Volunteers Trial in Dallas (Omeprazole, Sotorasib)
Recruiting
- Healthy Volunteers
- Omeprazole
- Sotorasib
-
Dallas, TexasLabcorp Clinical Research Unit Inc.
Aug 16, 2022
NSCLC Trial in Philadelphia (Sotorasib, 960 mg, oral daily dose for 4 weeks (28 days))
Recruiting
- Non-Small Cell Lung Cancer
- Sotorasib, 960 mg, oral daily dose for 4 weeks (28 days)
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 29, 2022
Metastatic Non Small Cell Lung Cancer, KRAS G12C Trial in Worldwide (Sotorasib, Lenvatinib)
Not yet recruiting
- Metastatic Non Small Cell Lung Cancer
- KRAS G12C
- Sotorasib
- Lenvatinib
-
Innsbruck, Austria
- +14 more
Sep 28, 2023
NSCLC Trial in Charleston (Sotorasib and Tarloxotinib)
Recruiting
- Non-Small Cell Lung Cancer
- Sotorasib and Tarloxotinib
-
Charleston, South CarolinaHollings Cancer Center at Medical University of South Carolina
Mar 28, 2022
Solid Tumor, Adult, Metastatic Solid Tumor, Metastatic NSCLC Trial in Adelaide (BBP-398, sotorasib)
Recruiting
- Solid Tumor, Adult
- +3 more
- BBP-398
- sotorasib
-
Adelaide, South Australia, AustraliaCancer Research SA
Aug 15, 2022
Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in United States (VS-6766 and sotorasib)
Recruiting
- Non Small Cell Lung Cancer
- KRAS Activating Mutation
- avutometinib (VS-6766) and sotorasib
-
Washington, District of Columbia
- +6 more
Jan 31, 2023
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (procedure, biological, drug)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Metastatic Malignant Solid Neoplasm
- Biopsy
- +5 more
- (no location specified)
Dec 2, 2022
Lung Cancer, NSCLC, Stage III, NSCLC Stage IV Trial in Drammen (sotorasib)
Recruiting
- Lung Cancer
- +6 more
- sotorasib
-
Drammen, Viken, NorwayVestre Viken Health Trust
May 30, 2022
RW Efficacy of Sotorasib in KRAS G12C-mutated Metastatic NSCLC
Recruiting
- Nsclc
- KRAS P.G12C
-
Paris, France
- +2 more
Aug 9, 2022
Healthy Participants Trial in Daytona Beach, Dallas (Sotorasib)
Completed
- Healthy Participants
- Sotorasib
-
Daytona Beach, Florida
- +1 more
Feb 7, 2022
Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer Trial (Sotorasib, Liposomal Irinotecan
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Sotorasib
- +5 more
- (no location specified)
Feb 11, 2022
Hepatic Impairment Trial in United States (Sotorasib)
Completed
- Hepatic Impairment
- Sotorasib
-
Tustin, California
- +4 more
Apr 1, 2022
Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)
Recruiting
- Lung Cancer
- AMG 510
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2022
Healthy Participants Trial in Daytona Beach (Rosuvastatin, Sotorasib)
Completed
- Healthy Participants
- Rosuvastatin
- Sotorasib
-
Daytona Beach, FloridaCovance Clinical Research Unit - Daytona Beach
Nov 19, 2021
Healthy Participants Trial in Dallas (AMG 510, Omeprazole, Famotidine)
Completed
- Healthy Participants
- AMG 510
- +2 more
-
Dallas, TexasCovance Clinical Research Unit, Inc
Oct 26, 2022